Urine-Based Spectroscopy/AI Platform for Early Detection of Multiple Cancers.

A new test uses artificial intelligence to identify cancer-indicative patterns of volatile organic compounds in urine. The test received U.S. FDA breakthrough device designation for early bladder cancer detection. The test is also designed for the early detection of other cancers including colorectal, stomach, pancreatic, prostate, kidney, bladder, breast, ovarian, cervical, and lung cancers.